Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD)

Biological Psychiatry

Volumn 53, Issue 11, 2003, Pages 1028-1042

  Sachs, Gary S ^a   Thase, Michael E ^b   Otto, Michael W ^a   Bauer, Mark ^d   Miklowitz, David ^e   Wisniewski, Stephen R ^c   Lavori, Philip ^f   Lebowitz, Barry ^g   Rudorfer, Mathew ^g   Frank, Ellen ^b   Nierenberg, Andrew A ^a   Fava, Maurizio ^a   Bowden, Charles ^h   Ketter, Terence ^f   Marangell, Lauren ⁱ   Calabrese, Joseph ^j   Kupfer, David ^b   Rosenbaum, Jerrold F ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d BROWN UNIVERSITY   (United States)

^e UNIVERSITY OF COLORADO   (United States)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^h UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

ⁱ BAYLOR COLLEGE OF MEDICINE   (United States)

^j CASE WESTERN RESERVE UNIVERSITY   (United States)

more..

Author keywords

Bipolar depression; Bipolar disorder; Effectiveness research; Relapse prevention

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; INOSITOL; LAMOTRIGINE; LITHIUM; OLANZAPINE; PAROXETINE; RISPERIDONE; VALPROIC ACID;

AGE DISTRIBUTION; BEHAVIOR THERAPY; BIPOLAR DISORDER; CERTIFICATION; CLINICAL PATHWAY; CLINICAL PRACTICE; CLINICAL TRIAL; COGNITIVE THERAPY; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DATA ANALYSIS; DISEASE COURSE; FAMILY THERAPY; FOLLOW UP; HEALTH CARE COST; HEALTH CENTER; HEALTH PROGRAM; HEALTH STATUS; HUMAN; LONGITUDINAL STUDY; MEDICAL EDUCATION; MENTAL HEALTH; METHODOLOGY; PATIENT CARE; PRIORITY JOURNAL; PSYCHIATRIST; PSYCHOLOGIC ASSESSMENT; PSYCHOSOCIAL CARE; PSYCHOTHERAPY; PUBLIC HEALTH; QUESTIONNAIRE; RANDOMIZATION; RATING SCALE; REGISTER; SELF REPORT; STANDARD; STATISTICAL ANALYSIS; TRAINING; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0038054362     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(03)00165-3     Document Type: Conference Paper

References (50)

1. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry. 159:2002;1-50.
2. Angst J., Sellaro R. Historical perspectives and natural history of bipolar disorder. Biol Psychiatry. 48:2000;445-457.
3. Baldessarini R., Tondo L., Hennen J. Treating the suicidal patient with bipolar disorder Reducing suicide risk with lithium . Ann N Y Acad Sci. 932:2001;24-38.
4. Bauer M.S., Callahan A.M., Jampala C., Petty F., Sajatovic M., Schaefer V. Clinical practice guidelines for bipolar disorder from the Department of Veterans Affairs. J Clin Psychiatry. 60:1999;9-21.
5. Beck A., Lester D., Trexler L. The measurement of pessimism The hopelessness scale . J Consult Clin Psychol. 42:1974;861-865.
6. Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 4:1961;561-571.
7. Boerlin H., Gitlin M., Zoeller L., Hammen C. Bipolar depression and antidepressant-induced mania A naturalistic study . J Clin Psychiatry. 59:1998;374-379.
8. Bauer M.S., Williford W.O., Dawson E.E., Akiskal H.S., Altshuler L., Fye C., et al. Principles of effectiveness trials and their implementation in VA Cooperative Study #430: "Reducing the efficacy-effectiveness gap in bipolar disorder." J Affect Disord. 67:2001;61-78.
9. Coryell W., Endicott J., Maser J.D., Keller M.B., Leon A.C., Akiskal H.S. Long-term stability of polarity distinctions in the affective disorders. Am J Psychiatry. 152:1995;385-390.
10. Costa PT Jr, McCrae RR (1988): Personality in adulthood: a six-year longitudinal study of self-reports and spouse ratings on the NEO Personality Inventory. J Pers Soc Psychol54:853-863.
11. Craighead W., Miklowitz D. Psychosocial interventions for bipolar disorder. J Clin Psychiatry. 61:(suppl):2000;58-64.
12. Davidson J.R., Book S.W., Colket J.T., Tupler L.A., Roth S., David D., et al. Assessment of a new self-rating scale for post-traumatic stress disorder. Psychol Med. 27:1997;153-160.
13. Dunner D., Fieve R. Clinical factors in lithium carbonate prophylaxis failure. Arch Gen Psychiatry. 30:1974;229-233.
14. Fawcett J., Scheftner W., Clark D., Hedeker D., Gibbons R., Coryell W. Clinical predictors of suicide in patients with major affective disorders A contolled prospective study . Am J Psychiatry. 144:1987;35-40.
15. Frank E., Swartz H., Kupfer D. Interpersonal and social rhythms therapy Managing the chaos of bipolar disorder . Biol Psychiatry. 48:2000;593-604.
16. Goldberg J (2001): Spontaneous depression versus biphasic cycling. Am J Psychiatry 158:325-326.
17. Goldberg J.F., Harrow M., Leon A. Lithium treatment of bipolar affective disorders under naturalistic followup conditions. Psychopharmacol Bull. 32:1996;47-54.
18. Goldstein M (1978): Further data concerning the relation between pre-morbid adjustment and paranoid symptomatology. Schizophr Bull 4:236-243.
19. Hooley J. Predictors of relapse in unipolar depressives Expressed emotion, marital distress, and perceived criticism . J Abnorm Psychol. 98:1989;229-235.
20. Huxley N.A., Parikh S.V., Baldessarini R.J. Effectiveness of psychosocial treatment in bipolar disorder State of the evidence . Harv Rev Psychiatry. 8:2000;126-140.
21. Keller M.B., Lavori P.W., Coryell W., Andreasen N.C., Endicott J., Clayton P.J., et al. Differential outcome of pure manic, mixed/cycling, and pure depressive episodes in patients with bipolar illness. JAMA. 255:1986;3138-3142.
22. Kessler R.C. The National Comorbidity Survey of the United States. Int Rev Psychiatry. 6:1994;365-376.
23. Kessler R.C., McGonagle K.A., Zhao S., Nelson C.B., Hughes M., Eshleman S., et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 51:1994;8-19.
24. Koukopulos A., Reginaldi D., Laddomada P., Floris G., Serra G., Tondo L. Course of the manic-depressive cycle and changes caused by treatments. Pharmacopsychiatry. 13:1980;156-167.
25. Liebowitz (1987). Social phobia. Mod Probl Pharmacopsychiatry 22:141-173.
26. Lish J.D., Dime-Meenan S., Whybrow P.C., Price R.A., Hirschfeld R.M.A. The National Depressive and Manic-depressive Association (DMDA) survey of bipolar members. J Affect Disord. 31:1994;281-294.
27. Maj M., Pirozzi R., Starace F. Previous pattern of course of the illness as a predictor of response to lithium prophylaxis in bipolar patients. J Affect Disord. 17:1989;237-241.
28. Miklowitz DJ, Otto MW (in press): New psychosocial interventions for bipolar disorder: A review of literature and introduction of the systematic treatment enhancement program. Trends in Evidence-Based Neuropsychiatry.
29. Miklowitz DJ, Simoneau TL, George EL, Richards JA, Kalbag A, Sachs-Ericsson N, et al (2002): Family-focused treatment of bipolar disorder: 1-year effects of a psychoeducational program in conjunction with pharmacotherapy. Biol Psychiatry 48:582-592.
30. Montgomery A. A new depression scale designed to be sensitive to change. Br J Psychiatry. 134:1979;382-389.
31. Murray C., Lopez A. Evidence-based health policy - lessons from the Global Burden of Disease Study. Science. 274:1996;740-743.
32. Norquist G., Hyman S. Advances in understanding and treating mental illness Implications for policy . Health Aff (Millwood). 18:1999;32-47.
33. Norquist G, Lebowitz B, Hyman S (1999): Expanding the frontier of treatment research. Prev Treatment. Available online at http://journals.apa.org/prevention/volume2/pre0020001a.html.
34. Oldfield R. The assessment and analysis of handedness The Edinburgh inventory . Neuropsychologia. 9:1971;97-113.
35. Otto M.W., Reilly-Harrington N., Sachs G.S. Psychoeducational and cognitive-behavioral strategies in the management of bipolar disorder. J Affect Disord. 73:2003;171-181.
36. Peduzzi P., Henderson W., Hartigan P., Lavori P. Analysis of randomized controlled trials. Epidemiol Rev. 24:2002;26-38.
37. Peterson C., Von Baeyer C., Abramson L., Metalsky G., Seligman M. The attributional style questionnaire. Cognit Ther Res. 6:1982;287-299.
38. Regier D.A., Farmer M.E., Rae D.S., Locke B.Z., Keith S.J., Judd L.L., Goodwin F.K. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemilogic Catchment Area (ECA) Study. JAMA. 264:1990;2511-2518.
39. Sachs G. Use of clonazepam for bipolar affective disorder. J Clin Psychiatry. 51:1990;31-34.
40. Sachs G (1996): Bipolar mood disorder: Practical strategies for acute and maintenance phase treatment. J Clin Psychopharmacol 16:32S-47S.
41. Sachs G, Printz D, Kahn D, Carpenter D (2000): The expert consensus guideline series. Medication treatment of bipolar disorder. Postgrad Med Apr;Spec No:1-104.
42. Sachs G.S., Guille C., McMurrich S. A clinical monitoring form for mood disorders. Bipolar Disord. 4:2002;323-327.
43. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.) The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10 . J Clin Psychiatry. 59:1998;22-33.
44. Simon G., Unutzer J. Health care utilization and costs among patients treated for bipolar disorder in an insured population. Psychiatr Serv. 50:1999;1303-1308.
45. Swartz H., Frank E. Psychotherapy for bipolar depression A phase-specific treatment strategy? Bipolar Disord. 3:2001;11-22.
46. Thase M., Sachs G. Bipolar depression Pharmacotherapy and related therapeutic strategies . Biol Psychiatry. 48:2000;558-572.
47. Thase M., Salloun I. Impact of substance abuse on the course and treatment of bipolar disorder. Bipolar Disord. 2:2000;269-280.
48. Weissman M., Warner V., Wickamaratne P., Prusoff B. Early-onset major depression in parents and their children. J Affect Disord. 15:1988;269-277.
49. Henter I., Wyatt R.J. An economic evaluation of manic-depressive illness - 1991. Soc Psychiatry Psychiatr Epidemiol. 30:1995;213-219.
50. Young R.C., Biggs J.T., Ziegler V.E., Meyer D.A. A rating scale for mania Reliability, validity, and sensitivity . Br J Psychiatry. 133:1978;429-435.